wen liang pan
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
1,064 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
yunbao pan
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University
Wuhan, China
Review Editor
Pharmacology of Anti-Cancer Drugs
boomi pandi
Alagappa University
Karaikudi, India
Review Editor
Pharmacology of Anti-Cancer Drugs
sudipta panja
University of Nebraska Medical Center
Omaha, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
giuliana papoff
National Research Council (CNR)
Roma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
bogdan parakhonskiy
Ghent University
Ghent, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
ashutosh pareek
Department of Pharmacy, Banasthali Vidyapith
Banasthali, India
Review Editor
Pharmacology of Anti-Cancer Drugs
sunju park
Daejeon University
Daejeon, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
jyoti parkash
Central University of Punjab
Bathinda, India
Review Editor
Pharmacology of Anti-Cancer Drugs
bhargav a. patel
Southern Illinois University Edwardsville
Edwardsville, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
hardik j patel
Memorial Sloan Kettering Cancer Center
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
ketan shirish patil
St. John's University
Taipei, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
nir peled
Soroka Medical Center
Beersheba, Israel
Review Editor
Pharmacology of Anti-Cancer Drugs
li peng
Shanxi Agricultural University
Jinzhong, China
Review Editor
Pharmacology of Anti-Cancer Drugs
vasudevarao penugurti
Duke University Medical Center, Duke University
Durham, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
silvia peppicelli
University of Florence
Florence, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs